Jun 27 2024
H.C. Wainwright Fireside Chat with Gene Mack - 5th Annual Neuro Perspectives Virtual Conference
|
Jun 27 2024
Business and Corporate Update Call with interim-CEO Gene Mack
|
Mar 19 2024
Public Ventures Discovery Day with Eric Richman
|
Feb 15 2024
Gain Therapeutics' 2024 R&D update with KOL and Analyst Insight
|
Dec 05 2023
FORCE Family Office/ Zacks Research Webinar
|
Sep 28 2023
Cantor Global Healthcare Conference
|
Sep 13 2023
FORCE Family Office Webinar
|
Jun 07 2023
Jefferies 2023 Healthcare Conference
|
May 23 2023
FORCE Family Office Webinar
|
Mar 29 2023
Fireside Chat On Computational Biology in Drug Discovery with Key Opinion Leaders
|
Mar 14 2023
Oppenheimer 33rd Annual Healthcare Conference
|
Jan 18 2023
Sidoti Small-Cap Virtual Investor Conference
|
Sep 12 2022
H.C. Wainwright 24th Annual Global Investment Conference
|
Jun 10 2022
Jefferies Healthcare Conference
|
May 24 2022
H.C. Wainwright Global Investment Conference
|
Apr 28 2022
B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
|
Apr 12 2022
Targeting glucocerebrosidase with structurally targeted allosteric regulators corrects abnormal phenotypes in models of Parkinson’s disease
|
Mar 29 2022
Cantor Rare Orphan Disease Summit
|
Mar 27 2022
2022 Glycolipid and Sphingolipid Biology GRC
|
Mar 27 2022
2022 Glycolipid and Sphingolipid Biology GRC
|
Mar 17 2022
Oppenheimer 32nd Annual Healthcare Conference
|
Mar 15 2022
Krabbe Translational Research Network Meeting
|
Mar 15 2022
AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders
|
Feb 07 2022
18th Annual Worldsymposium On Lysosomal Disease Research Development of Structurally Targeted Allosteric Regulators for the Treatment of Neuronopathic Gaucher Disease
|
Feb 04 2022
Gain Therapeutics R&D Day
|
Nov 11 2021
The Society Of Neuroscience Annual Meeting
|
Nov 10 2021
The Michael J. Fox Foundation’s Parkinson's Disease Therapeutics Webinars
|